tirzepatide and yeast infections First FDA-Approved Treatment for Chronic Infection + Eli Lilly Obesity Drug Shows Promise in Trials – Xtalks Life Science Podcast Ep. 59 Ozempic (semaglutide) and vaginal health
Description
doi: 10.1192/bjp.164.2.177
Once the drug is stopped, hunger hormones (ghrelin, neuropeptide Y) rebound dramatically, driving hyperphagia (excessive eating)
Semaglutide, a prominent medication in personalized weight loss, is often at the forefront of these discussions
For more news and advice, follow the SemaPen blog
Karaki, S
Tirzepatide (Zepbound) is FDA-approved for chronic weight management in eligible adults with obesity or overweight with at least one weight-related condition, and for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity
